Agree. The Bill Harris guy I think has ties to DS industry. Possible conflict of interest so he wants to favor products he can sell or be associated with (DHA)
Attia touts that he is clean, isn't swayed by taking money from sponsors. But the guy he interviews doesn't seem neutral.
They mention the great benefits of REDUCE-IT but just gloss over the great life-saving and health-improving benefits.
They get into the weeds about mechanism of action of fats, etc. But just miss the big picture of the benefits of EPA.
The track record of EPADEL in Japan, etc. screams for greater use of Vascepa in patients with elevated trigs (>135)
Market Data 
Markets 
AI
